针对BRD4的PROTAC与化学治疗药物协同对抗骨髓瘤细胞系
Clemens Lang1, Sandra Stickler2, Barbara Rath2
1Department of Trauma Surgery, Hospital Donaustadt, Vienna, Austria.
Anticancer research
|February 29, 2024
概括
新型原体抑制剂 (BETi) PROTACs与化学疗法对骨髓瘤细胞产生协同效应. 这种组合疗法,特别是与BET药物和多克索鲁比辛的组合疗法,为晚期骨髓瘤提供了一个有前途的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 晚期骨肉瘤的预后不好,需要新的向治疗,特别是转移性疾病.
- 代酶抑制剂 (BETi) 是表观遗传调节剂,具有已证明的抗瘤作用.
- 当与化疗药物相结合时,蛋白质溶解向嵌合体 (PROTACs) 提供了向蛋白质的增强降解.
研究的目的:
- 研究BET抑制剂 (BETi) 的疗效,包括JQ1,dBET57和MZ1 PROTACs,结合细胞毒药物对抗骨髓瘤细胞系.
- 评估这些联合治疗的协同作用和毒性.
主要方法:
- 在骨髓瘤细胞系 (HOS,Saos-2,MG-63,G292) 上进行了化学敏感性测试.
- 细胞被单独使用BET导向药物或与西斯丁,多克索鲁比辛,托波特干和格姆西塔结合治疗.
- 细胞活力被评估以确定药物的有效性和协同作用.
主要成果:
- BET降解剂显示出显著的毒性,特别是在HOS细胞中.
- 在BET药物和化疗药物之间观察到协同作用,特别是在耐化学反应的Saos-2细胞和MG-63细胞中.
- 与多克索鲁比辛和MZ1-托波特干对结合的BET药物显示出毒性强化. AXL,BCL-X和其他蛋白质的表达被BET剂降低.
结论:
- 新型BET PROTAC与化疗药物的组合为骨髓瘤提供了潜在的新疗法策略.
- 这种方法可以改善骨髓瘤患者的治疗结果.
- 进入临床试验的口服PROTACs的开发支持了这种治疗途径.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K